BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20184741)

  • 21. Poor prognosis in acute lymphoblastic leukemia may relate to promoter hypermethylation of cancer-related genes.
    Roman-Gomez J; Jimenez-Velasco A; Barrios M; Prosper F; Heiniger A; Torres A; Agirre X
    Leuk Lymphoma; 2007 Jul; 48(7):1269-82. PubMed ID: 17613754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenetic regulation of human cancer/testis antigen gene, HAGE, in chronic myeloid leukemia.
    Roman-Gomez J; Jimenez-Velasco A; Agirre X; Castillejo JA; Navarro G; San Jose-Eneriz E; Garate L; Cordeu L; Cervantes F; Prosper F; Heiniger A; Torres A
    Haematologica; 2007 Feb; 92(2):153-62. PubMed ID: 17296563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation.
    Corn PG; Kuerbitz SJ; van Noesel MM; Esteller M; Compitello N; Baylin SB; Herman JG
    Cancer Res; 1999 Jul; 59(14):3352-6. PubMed ID: 10416592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant DNA methylation of key genes and Acute Lymphoblastic Leukemia.
    Rahmani M; Talebi M; Hagh MF; Feizi AAH; Solali S
    Biomed Pharmacother; 2018 Jan; 97():1493-1500. PubMed ID: 29793312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The dual role of HLXB9 in leukemia.
    Ferguson S; Gautrey HE; Strathdee G
    Pediatr Blood Cancer; 2011 Mar; 56(3):349-52. PubMed ID: 21069786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental and integrative analyses identify an ETS1 network downstream of BCR-ABL in chronic myeloid leukemia (CML).
    Desterke C; Voldoire M; Bonnet ML; Sorel N; Pagliaro S; Rahban H; Bennaceur-Griscelli A; Cayssials E; Chomel JC; Turhan AG
    Exp Hematol; 2018 Aug; 64():71-83.e8. PubMed ID: 29733872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP).
    Iacobucci I; Storlazzi CT; Cilloni D; Lonetti A; Ottaviani E; Soverini S; Astolfi A; Chiaretti S; Vitale A; Messa F; Impera L; Baldazzi C; D'Addabbo P; Papayannidis C; Lonoce A; Colarossi S; Vignetti M; Piccaluga PP; Paolini S; Russo D; Pane F; Saglio G; Baccarani M; Foà R; Martinelli G
    Blood; 2009 Sep; 114(10):2159-67. PubMed ID: 19589926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
    Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
    J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. JunB gene expression is inactivated by methylation in chronic myeloid leukemia.
    Yang MY; Liu TC; Chang JG; Lin PM; Lin SF
    Blood; 2003 Apr; 101(8):3205-11. PubMed ID: 12506033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genome wide analysis of acute myeloid leukemia reveal leukemia specific methylome and subtype specific hypomethylation of repeats.
    Saied MH; Marzec J; Khalid S; Smith P; Down TA; Rakyan VK; Molloy G; Raghavan M; Debernardi S; Young BD
    PLoS One; 2012; 7(3):e33213. PubMed ID: 22479372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methylation status of RASSF1A in patients with chronic myeloid leukemia.
    Avramouli A; Tsochas S; Mandala E; Katodritou E; Ioannou M; Ritis K; Speletas M
    Leuk Res; 2009 Aug; 33(8):1130-2. PubMed ID: 19193434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lineage involvement by BCR/ABL in Ph+ lymphoblastic leukemias: chronic myelogenous leukemia presenting in lymphoid blast vs Ph+ acute lymphoblastic leukemia.
    Anastasi J; Feng J; Dickstein JI; Le Beau MM; Rubin CM; Larson RA; Rowley JD; Vardiman JW
    Leukemia; 1996 May; 10(5):795-802. PubMed ID: 8656674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.
    Zion M; Ben-Yehuda D; Avraham A; Cohen O; Wetzler M; Melloul D; Ben-Neriah Y
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10722-6. PubMed ID: 7938018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detailed mapping of methylcytosine positions at the CpG island surrounding the Pa promoter at the bcr-abl locus in CML patients and in two cell lines, K562 and BV173.
    Fajkusová L; Fajkus J; Polácková K; Fulnecek J; Dvoráková D; Krahulcová E
    Blood Cells Mol Dis; 2000 Jun; 26(3):193-204. PubMed ID: 10950939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Large-scale CpG methylation analysis identifies novel candidate genes and reveals methylation hotspots in acute lymphoblastic leukemia.
    Taylor KH; Pena-Hernandez KE; Davis JW; Arthur GL; Duff DJ; Shi H; Rahmatpanah FB; Sjahputera O; Caldwell CW
    Cancer Res; 2007 Mar; 67(6):2617-25. PubMed ID: 17363581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical significance of BCR-ABL fusion gene subtypes in chronic myelogenous and acute lymphoblastic leukemias.
    Ye YX; Zhou J; Zhou YH; Zhou Y; Song XB; Wang J; Lin L; Ying BW; Lu XJ
    Asian Pac J Cancer Prev; 2014; 15(22):9961-6. PubMed ID: 25520136
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide DNA methylation analysis in precursor B-cells.
    Almamun M; Levinson BT; Gater ST; Schnabel RD; Arthur GL; Davis JW; Taylor KH
    Epigenetics; 2014 Dec; 9(12):1588-95. PubMed ID: 25484143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of DNA hypermethylation in the pathogenesis and prognosis of acute lymphoblastic leukemia.
    Roman-Gomez J; Castillejo JA; Jimenez A; Barrios M; Heiniger A; Torres A
    Leuk Lymphoma; 2003 Nov; 44(11):1855-64. PubMed ID: 14738136
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors.
    Sun B; Jiang G; Zaydan MA; La Russa VF; Safah H; Ehrlich M
    Cancer Res; 2001 Sep; 61(18):6931-7. PubMed ID: 11559572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic p16 abnormalities in the progression of chronic myeloid leukemia into blast crisis: a sequential study in 42 patients.
    Hernández-Boluda JC; Cervantes F; Colomer D; Vela MC; Costa D; Paz MF; Esteller M; Montserrat E
    Exp Hematol; 2003 Mar; 31(3):204-10. PubMed ID: 12644017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.